2020 – well, where do we begin? It’s been an eventful year for RedKnight and all of our clients, with the Covid-19 pandemic bringing challenges that none of us could have foreseen. We’ve spent the best part of the year working from home, more committed than ever to making innovation funding easier for start-ups and SMEs. It’s fair to say we lost count of all the Zoom meetings a long time ago!

Projects

While the year has had its challenges, it’s also brought highpoints that we as a business are extremely proud of. We’ve supported projects from a range of sectors, from digital health to advanced materials. In particular, we were proud to support the innovative medtech start-up, GeneFirst, with a successful application to Horizon 2020’s Innovative Medicine Initiative, winning €2.8 million. The competition was extremely competitive; of 144 applications, just 8 projects received funding. An impressive feat, considering RedKnight had just 14 days to develop and write the 70-page application! To read more about GeneFirst’s Rapid-Covid project, and the other successful projects we’ve supported this year, visit our website.

2020 in Numbers

It’s been another busy year of bid writing, with 26 proposals submitted at the time of writing. We are proud to have secured a further £3.7 million in grant funding, bringing our total to almost £10 million! Our average application score now stands at 78%, with a success rate of over 42%.

Overall, 2020 has been a great year for RedKnight, and we look forward to taking on new challenges in 2021. We’d like to take the opportunity to say a huge thank you to all of our clients, both new and old, who’ve trusted us to support their proposals. We look forward to following your projects in 2021 and working with you again in the future!

Looking for grant funding in 2021? Subscribe to our free monthly newsletter to receive the latest opportunities direct to your inbox.